In vitro design of a novel lytic bacteriophage cocktail with therapeutic potential against organisms causing diabetic foot infections

Journal of Medical Microbiology

Volumn 63, Issue PART 8, 2014, Pages 1055-1065

  Mendes, João J ^a,b   Leandro, Clara ^a   Mottola, Carla ^a,c   Barbosa, Raquel ^a   Silva, Filipa A ^a   Oliveira, Manuela ^c   Vilela, Cristina L ^c   Melo Cristino, José ^d   Górski, Andrzej ^e   Pimentel, Madalena ^a,f   São José, Carlos ^a,f   Cavaco Silva, Patrícia ^a,g   Garcia, Miguel ^a  

^a TechnoPhage SA   (Portugal)

^b Central Lisbon Hospital Centre   (Portugal)

^c Interdisciplinary Center of Research in Animal Health   (Portugal)

^d Institute of Microbiology   (Portugal)

^e INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^f UNIVERSITY OF LISBON   (Portugal)

^g INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER BAUMANNII; BACTERIOPHAGES; BIOFILMS; DIABETIC FOOT; HUMANS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84905174218     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.071753-0     Document Type: Article

References (58)

1. Abedon, S. T. (2009). Kinetics of phage-mediated biocontrol of bacteria. Foodborne Pathog Dis 6, 807-815.
2. Abedon, S. T. (2010). The 'nuts and bolts' of phage therapy. Curr Pharm Biotechnol 11, 1.
3. Abedon, S. T. & Thomas-Abedon, C. (2010). Phage therapy pharmacology. Curr Pharm Biotechnol 11, 28-47.
4. Abedon, S. T., Kuhl, S. J., Blasdel, B. G. & Kutter, E. M. (2011). Phage treatment of human infections. Bacteriophage 1, 66-85.
5. Ackermann, H.-W. (2009). Phage classification and characterization. In Bacteriophages Methods and Protocols, pp. 127-140. Edited by M. R. J. Clokie & A. M. Kropinski. Clifton, NJ: Humana Press.
6. Adams, M. H. (1959). Methods of study of bacterial viruses: isolation of bacterial viruses. In Bacteriophages, pp. 447-449. New York: Interscience.
7. Ansaldi, M. (2012). Cell biology perspectives in phage biology. Front Biosci (Elite Ed) 4, 1823-1829.
8. Armon, R. & Kott, Y. (1993). A simple, rapid and sensitive presence/ absence detection test for bacteriophage in drinking water. J Appl Bacteriol 74, 490-496.
9. Bruynoghe, R. & Maisin, J. (1921). Essais de thérapeutique au moyen du bacteriophage. C R Soc Biol 85, 1120-1121 (in French).
10. Capparelli, R., Parlato, M., Borriello, G., Salvatore, P. & Iannelli, D. (2007). Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob Agents Chemother 51, 2765-2773.
11. Carlton, R. M. (1999). Phage therapy: past history and future prospects. Arch Immunol Ther Exp (Warsz) 47, 267-274.
12. Cerca, N., Martins, S., Cerca, F., Jefferson, K. K., Pier, G. B., Oliveira, R. & Azeredo, J. (2005). Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother 56, 331-336.
13. Ceyssens, P. J., Lavigne, R., Mattheus, W., Chibeu, A., Hertveldt, K., Mast, J., Robben, J. & Volckaert, G. (2006). Genomic analysis of Pseudomonas aeruginosa phages LKD16 and LKA1: establishment of the phiKMV subgroup within the T7 supergroup. J Bacteriol 188, 6924-6931.
14. Ceyssens, P. J., Brabban, A., Rogge, L., Lewis, M. S., Pickard, D., Goulding, D., Dougan, G., Noben, J. P., Kropinski, A. & other authors (2010). Molecular and physiological analysis of three Pseudomonas aeruginosa phages belonging to the "N4-like viruses". Virology 405, 26-30.
15. Chan, B. K. & Abedon, S. T. (2012). Phage therapy pharmacology phage cocktails. Adv Appl Microbiol 78, 1-23.
16. Chang, K. C., Lin, N. T., Hu, A., Lin, Y. S., Chen, L. K. & Lai, M. J. (2011). Genomic analysis of bacteriophage wAB1, a wKMV-like virus infecting multidrug-resistant Acinetobacter baumannii. Genomics 97, 249-255.
17. Chao, L., Levin, B. R. & Stewart, F. M. (1977). A complex community in a simple habitat: an experimental study with bacteria and phage. Ecology 58, 369-378.
18. Chibeu, A., Lingohr, E. J., Masson, L., Manges, A., Harel, J., Ackermann, H. W., Kropinski, A. M. & Boerlin, P. (2012). Bacteriophages with the ability to degrade uropathogenic Escherichia coli biofilms. Viruses 4, 471-487.
19. Chopra, I., Hodgson, J., Metcalf, B. & Poste, G. (1997). The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics. Antimicrob Agents Chemother 41, 497-503.
20. Cornelissen, A., Ceyssens, P. J., T'Syen, J., Van Praet, H., Noben, J. P., Shaburova, O. V., Krylov, V. N., Volckaert, G. & Lavigne, R. (2011). The T7-related Pseudomonas putida phage w15 displays virionassociated biofilm degradation properties. PLoS ONE 6, e18597.
21. Gill, J. J. & Hyman, P. (2010). Phage choice, isolation, and preparation for phage therapy. Curr Pharm Biotechnol 11, 2-14.
22. Goode, D., Allen, V. M. & Barrow, P. A. (2003). Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages. Appl Environ Microbiol 69, 5032-5036.
23. Gu, J., Liu, X., Lu, R., Li, Y., Song, J., Lei, L., Sun, C., Feng, X., Du, C. & other authors (2012). Complete genome sequence of Staphylococcus aureus bacteriophage GH15. J Virol 86, 8914-8915.
24. Hughes, K. A., Sutherland, I. W. & Jones, M. V. (1998). Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144, 3039-3047.
25. Kasman, L. M., Kasman, A., Westwater, C., Dolan, J., Schmidt, M. G. & Norris, J. S. (2002). Overcoming the phage replication threshold: a mathematical model with implications for phage therapy. J Virol 76, 5557-5564.
26. Kropinski, A., Mazzocco, A., Waddell, T., Lingohr, E. & Johnson, R. (2009). Enumeration of bacteriophages by double agar overlay plaque assay. In Bacteriophages Methods and Protocols, vol. 1.
27. Isolation, Characterization, and Interactions (Methods in Molecular Biology) series, vol. 501, pp. 69-76. Edited by M. Clokie & A. Kropinski. New York: Humana Press, Springer Science + Business Media.
28. Kumari, S., Harjai, K. & Chhibber, S. (2010). Topical treatment of Klebsiella pneumoniae B5055 induced burn wound infection in mice using natural products. J Infect Dev Ctries 4, 367-377.
29. Kussell, E., Kishony, R., Balaban, N. Q. & Leibler, S. (2005). Bacterial persistence: a model of survival in changing environments. Genetics 169, 1807-1814.
30. Kutter, E. (2009). Phage host range and efficiency of plating. Methods Mol Biol 501, 141-149.
31. Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S. & Abedon, S. T. (2010). Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 11, 69-86.
32. Lammens, E., Ceyssens, P. J., Voet, M., Hertveldt, K., Lavigne, R. & Volckaert, G. (2009). Representational difference analysis (RDA) of bacteriophage genomes. J Microbiol Methods 77, 207-213.
33. Lavery, L. A., Armstrong, D. G., Wunderlich, R. P., Mohler, M. J., Wendel, C. S. & Lipsky, B. A. (2006). Risk factors for foot infections in individuals with diabetes. Diabetes Care 29, 1288-1293.
34. Lavigne, R. Burkal'tseva, M. V. Robben, J. Sykilinda, N. N. Kurochkina, L. P. Grymonprez, B. Jonckx, B. Krylov, V. N. Mesyanzhinov, V. V. & Volckaert, G. (2003). The genome of bacteriophage ØKMV, a T7-like virus infecting Pseudomonas aeruginosa. Virology 312, 49-59.
35. Lavigne, R., Darius, P., Summer, E. J., Seto, D., Mahadevan, P., Nilsson, A. S., Ackermann, H. W. & Kropinski, A. M. (2009). Classification of Myoviridae bacteriophages using protein sequence similarity. BMC Microbiol 9, 224.
36. Lenski, R. E. & Levin, B. R. (1985). Constraints on the coevolution of bacteria and virulent phage: a model, some experiments and predictions for natural communities. Am Nat 125, 585-602.
37. Lipsky, B. A., Berendt, A. R., Deery, H. G., Embil, J. M., Joseph, W. S., Karchmer, A. W., LeFrock, J. L., Lew, D. P., Mader, J. T. & other authors (2004). Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 39, 885-910.
38. Loc-Carrillo, C., Wu, S. & Beck, J. P. (2012). Phage therapy of wounds and related purulent infections. In Bacteriophages in Health and Disease. pp. 185-202. Edited by P. Hyman. Cambridge, USA: CAB International.
39. Mendes, J. J., Marques-Costa, A., Vilela, C., Neves, J., Candeias, N., Cavaco-Silva, P. & Melo-Cristino, J. (2012). Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diabetes Res Clin Pract 95, 153-161.
40. Mendes, J. J., Leandro, C., Corte-Real, S., Barbosa, R., Cavaco-Silva, P., Melo-Cristino, J., Gó rski, A. & Garcia, M. (2013). Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds. Wound Repair Regen 21, 595-603.
41. Merabishvili, M., Pirnay, J. P., Verbeken, G., Chanishvili, N., Tediashvili, M., Lashkhi, N., Glonti, T., Krylov, V., Mast, J. & other authors (2009). Quality-controlled small-scale production of a welldefined bacteriophage cocktail for use in human clinical trials. PLoS ONE 4, e4944.
42. Miedzybrodzki, R., Borysowski, J., Weber-Dabrowska, B. Fortuna, W. Letkiewicz, S., Szufnarowski, K., Pawełczyk, Z., Rogóz, P., Kłak, M. & other authors (2012). Clinical aspects of phage therapy. Adv Virus Res 83, 73-121.
43. Miller, H. (1987). Practical aspects of preparing phage and plasmid DNA: growth, maintenance, and storage of bacteria and bacteriophage. Methods Enzymol 152, 145-170.
44. Mottola, C., Mendes, J., Cavaco-Silva, P., Melo-Cristino, J. & Oliveira, M. (2013). Relevance of inoculum size on biofilm formation by diabetic foot bacterial isolates. In Portuguese Congress of Microbiology and Biotechnology 2013. 6-8 December, Aveiro Portugal.
45. Murray, P., Baron, E., Jorgensen, J., Pfaller, M. & Yolken, R. (2003). Manual of Clinical Microbiology, 8th edn. Washington, DC: American Society for Microbiology.
46. NCCLS (1999). Methods for Determining Bactericidal Activity of Antimicrobial Agents: approved guideline M26-A. Wayne, PA: National Committee for Clinical Laboratory Standards.
47. O'Flaherty, S., Coffey, A., Edwards, R., Meaney, W., Fitzgerald, G. F. & Ross, R. P. (2004). Genome of staphylococcal phage K: a new lineage of Myoviridae infecting Gram-positive bacteria with a low G+C content. J Bacteriol 186, 2862-2871.
48. O'Flaherty, S., Ross, R. P., Meaney, W., Fitzgerald, G. F., Elbreki, M. F. & Coffey, A. (2005). Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. Appl Environ Microbiol 71, 1836-1842.
49. O'Flynn, G., Ross, R. P., Fitzgerald, G. F. & Coffey, A. (2004). Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157: H7. Appl Environ Microbiol 70, 3417-3424.
50. Percival, S. L., Hill, K. E., Williams, D. W., Hooper, S. J., Thomas, D. W. & Costerton, J. W. (2012). A review of the scientific evidence for biofilms in wounds. Wound Repair Regen 20, 647-657.
51. Pettit, R. K., Weber, C. A., Kean, M. J., Hoffmann, H., Pettit, G. R., Tan, R., Franks, K. S. & Horton, M. L. (2005). Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chemother 49, 2612-2617.
52. Pettit, R. K., Weber, C. A. & Pettit, G. R. (2009). Application of a high throughput Alamar blue biofilm susceptibility assay to Staphylococcus aureus biofilms. Ann Clin Microbiol Antimicrob 8, 28.
53. Popova, A. V., Zhilenkov, E. L., Myakinina, V. P., Krasilnikova, V. M. & Volozhantsev, N. V. (2012). Isolation and characterization of wide host range lytic bacteriophage AP22 infecting Acinetobacter baumannii. FEMS Microbiol Lett 332, 40-46.
54. Rabinovitch, A., Aviram, I. & Zaritsky, A. (2003). Bacterial debris-an ecological mechanism for coexistence of bacteria and their viruses. J Theor Biol 224, 377-383.
55. Sahm, D. F., Deane, J., Pillar, C. M. & Fernandes, P. (2013). In vitro activity of CEM-102 (fusidic acid) against prevalent clones and resistant phenotypes of Staphylococcus aureus. Antimicrob Agents Chemother 57, 4535-4536.
56. Sambrook, J., Fritsch, E. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
57. Turnidge, J. & Collignon, P. (1999). Resistance to fusidic acid. Int J Antimicrob Agents 12 (Suppl. 2), S35-S44.
58. Wild, S., Roglic, G., Green, A., Sicree, R. & King, H. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053.